论文信息 - Predictors for Improvement in Patient-Reported Outcomes: Post-Hoc Analysis of a Phase 3 Randomized, Open-Label Study of Eculizumab and Ravulizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) - 字舞流文

Predictors for Improvement in Patient-Reported Outcomes: Post-Hoc Analysis of a Phase 3 Randomized, Open-Label Study of Eculizumab and Ravulizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

H. Schrezenmeier | K. Johnston | J. Lee | T. Devos | S. Okamoto | R. Peffault de Latour | E. Popoff | A. Kulasekararaj | Jimmy Wang | P. Gustovic | I. Tomazos | A. Cheung | Lindsay D Mitchell | Y. Patel | R. Wells | A. Wang